NL8403308A - Oxazolidinen, werkwijze ter bereiding daarvan, farmaceutisch preparaat, dat een dergelijk oxazolidine bevat, alsmede de toepassing van deze verbindingen. - Google Patents

Oxazolidinen, werkwijze ter bereiding daarvan, farmaceutisch preparaat, dat een dergelijk oxazolidine bevat, alsmede de toepassing van deze verbindingen. Download PDF

Info

Publication number
NL8403308A
NL8403308A NL8403308A NL8403308A NL8403308A NL 8403308 A NL8403308 A NL 8403308A NL 8403308 A NL8403308 A NL 8403308A NL 8403308 A NL8403308 A NL 8403308A NL 8403308 A NL8403308 A NL 8403308A
Authority
NL
Netherlands
Prior art keywords
phenyl
compounds according
formula
lower alkyl
optionally
Prior art date
Application number
NL8403308A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6070/83A external-priority patent/CH655931A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL8403308A publication Critical patent/NL8403308A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL8403308A 1983-11-10 1984-10-31 Oxazolidinen, werkwijze ter bereiding daarvan, farmaceutisch preparaat, dat een dergelijk oxazolidine bevat, alsmede de toepassing van deze verbindingen. NL8403308A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH6070/83A CH655931A5 (en) 1983-11-10 1983-11-10 Oxazolidines
CH607083 1983-11-10
CH449984 1984-09-20
CH449984 1984-09-20

Publications (1)

Publication Number Publication Date
NL8403308A true NL8403308A (nl) 1985-06-03

Family

ID=25695620

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8403308A NL8403308A (nl) 1983-11-10 1984-10-31 Oxazolidinen, werkwijze ter bereiding daarvan, farmaceutisch preparaat, dat een dergelijk oxazolidine bevat, alsmede de toepassing van deze verbindingen.

Country Status (22)

Country Link
US (2) US4743604A (de)
AT (1) AT387771B (de)
AU (1) AU576531B2 (de)
BE (1) BE900983A (de)
CA (1) CA1249992A (de)
DE (1) DE3438411A1 (de)
DK (1) DK520584A (de)
ES (1) ES8606863A1 (de)
FI (1) FI844152L (de)
FR (1) FR2554814B1 (de)
GB (1) GB2149405B (de)
HU (1) HU193465B (de)
IL (1) IL73427A (de)
IT (1) IT1177033B (de)
LU (1) LU85631A1 (de)
MC (1) MC1641A1 (de)
NL (1) NL8403308A (de)
NO (1) NO844501L (de)
NZ (1) NZ210105A (de)
PH (1) PH22462A (de)
PT (1) PT79485B (de)
SE (1) SE463099B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
FI892341A7 (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanoliamiinijohdannaisia
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
SK111195A3 (en) * 1994-09-13 1997-06-04 Sandoz Technology Ltd Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8036727B2 (en) * 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
EP1874178A4 (de) 2005-04-13 2009-12-09 Glucolight Corp Verfahren zur datenreduzierung und kalibrierung eines blutzuckermonitors auf oct-basis
US8571617B2 (en) * 2008-03-04 2013-10-29 Glt Acquisition Corp. Flowometry in optical coherence tomography for analyte level estimation
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA979912A (en) * 1970-06-22 1975-12-16 Frederic P. Hauck Tetrahydronaphthyloxyaminopropanols and related compounds
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES

Also Published As

Publication number Publication date
FR2554814B1 (fr) 1988-03-11
IT1177033B (it) 1987-08-26
IL73427A (en) 1988-02-29
DE3438411A1 (de) 1985-05-30
ES537487A0 (es) 1986-05-01
GB2149405B (en) 1987-07-01
BE900983A (fr) 1985-05-06
FR2554814A1 (fr) 1985-05-17
SE8405632L (sv) 1985-05-11
IT8423307A0 (it) 1984-10-25
NO844501L (no) 1985-05-13
IT8423307A1 (it) 1986-04-25
MC1641A1 (fr) 1986-01-09
IL73427A0 (en) 1985-02-28
ES8606863A1 (es) 1986-05-01
FI844152A7 (fi) 1985-05-11
HU193465B (en) 1987-10-28
US4871755A (en) 1989-10-03
CA1249992A (en) 1989-02-14
NZ210105A (en) 1988-10-28
PT79485B (en) 1987-01-13
SE463099B (sv) 1990-10-08
ATA355384A (de) 1988-08-15
AU3527584A (en) 1985-05-16
FI844152L (fi) 1985-05-11
GB2149405A (en) 1985-06-12
AU576531B2 (en) 1988-09-01
AT387771B (de) 1989-03-10
FI844152A0 (fi) 1984-10-22
DK520584D0 (da) 1984-11-01
PH22462A (en) 1988-09-12
HUT36103A (en) 1985-08-28
US4743604A (en) 1988-05-10
PT79485A (en) 1984-12-01
DK520584A (da) 1985-05-11
SE8405632D0 (sv) 1984-11-09
LU85631A1 (fr) 1986-06-04
GB8428335D0 (en) 1984-12-19

Similar Documents

Publication Publication Date Title
NL8403308A (nl) Oxazolidinen, werkwijze ter bereiding daarvan, farmaceutisch preparaat, dat een dergelijk oxazolidine bevat, alsmede de toepassing van deze verbindingen.
US4585796A (en) Novel phenethanolamines
US5064863A (en) Phenoxypropanolamines and pharmaceutical use
US4800206A (en) Pyridine-ethanolamine derivatives
EP0040000A1 (de) Arylethanolamin-Derivate, ihre Herstellung und Verwendung in pharmazeutischen Zusammensetzungen
US4652679A (en) Aziridine and phenethanolamine derivatives having antiobesity and anti-hyperglycaemic acitivity
JPH06340661A (ja) オキサゾリジノン化合物
US4783460A (en) Morpholine derivatives, compositions and medicinal uses
US5017619A (en) Phenethanolamine derivatives
US5166218A (en) Phenoxypropanolamines and pharmaceutical compositions thereof
MC2042A1 (fr) Derives de propanolamine
AU617353B2 (en) Pyridylethanolamines
US4665072A (en) Morpholine derivatives, compositions and method of use
JPS60115568A (ja) オキサゾリジン類

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: HOFFMANN-LA ROCHE AG. F. -

BV The patent application has lapsed